Grant: A randomized, multicenter phase II study to explore whether biomarkers correlate with treatment outcome in chemo-naive patients with advanced or recurrent non-squamous non-small cell lung cancer, who receive treatment with bevacizumab (at a dose of either 7,5mg.kg or 15mg/kg) in addition to carboplain-based chemotherapy (gemcitabine or paclitaxed)
| Project Title |
A randomized, multicenter phase II study to explore whether biomarkers correlate with treatment outcome in chemo-naive patients with advanced or recurrent non-squamous non-small cell lung cancer, who receive treatment with bevacizumab (at a dose of either 7,5mg.kg or 15mg/kg) in addition to carboplain-based chemotherapy (gemcitabine or paclitaxed)
|
|---|---|
| Principal Investigator | Ho, James Chung Man (Principal investigator) |
| Co-Investigator(s) |
Dr Wang Julie Kwan Ling
(Co-Investigator)
Dr Lam David Chi Leung (Co-Investigator) Dr Wong Matthew King Yan (Co-Investigator) Dr Lam Jamie Chung Mei (Co-Investigator) |
| Funding Year |
2008/2009
|
| Amount |
271260
|
| Panel | Medicine |
| Start Date |
01-12-2008
|
| Expected Completion |
31-12-2011
|
| Status |
On-going
|
| Keywords | biomarkers |
| Discipline | Respiration, Cancer |
| Grant Type/Funding Scheme | Pharmaceutical Industry - General Award |
| Duration |
37
|
[Coming Soon]